Lanean...
Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertension
Sildenafil is a phosphodiesterase type-5 inhibitor approved for treatment of pulmonary arterial hypertension (PAH) in adults. Data from pediatric trials demonstrate a similar acute safety profile to the adult population but have raised concerns regarding the safety of long-term use in children. Inte...
Gorde:
| Argitaratua izan da: | Drug Healthc Patient Saf |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687613/ https://ncbi.nlm.nih.gov/pubmed/26719728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S65571 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|